A man experienced severe health complications after losing 30 percent of his body weight in six months using tirzepatide, a new weight loss drug. Researchers at the University of Colorado reported the case in JAMA Internal Medicine. The 62-year-old, who had obesity, Type 1 diabetes, and hypothyroidism, was taking a weight-based dose of levothyroxine. After significant weight loss, he developed atrial fibrillation due to an excess of thyroid hormone.

You are viewing a single thread.
View all comments View context
3 points

True; the rapidity of the weight loss is one of the main draws of GLP-1 agonists, and that shifts the timeframe for adjusting those meds. My thyroid levels get checked about twice a year, for example.

permalink
report
parent
reply

Health - Resources and discussion for everything health-related

!health@lemmy.world

Create post

Health: physical and mental, individual and public.

Discussions, issues, resources, news, everything.

See the pinned post for a long list of other communities dedicated to health or specific diagnoses. The list is continuously updated.

Nothing here shall be taken as medical or any other kind of professional advice.

Commercial advertising is considered spam and not allowed. If you’re not sure, contact mods to ask beforehand.

Linked videos without original description context by OP to initiate healthy, constructive discussions will be removed.

Regular rules of lemmy.world apply. Be civil.

Community stats

  • 2.1K

    Monthly active users

  • 652

    Posts

  • 2.1K

    Comments